Namikoshi Tamehachi, Fujimoto Sohachi, Yorimitsu Daisuke, Ihoriya Chieko, Fujimoto Yasuo, Komai Norio, Sasaki Tamaki, Kashihara Naoki
Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan.
Nephrology (Carlton). 2015 Sep;20(9):585-90. doi: 10.1111/nep.12483.
Hypertension contributes critically to the development of renal arteriolosclerosis in chronic kidney disease (CKD), but the impact of vascular function indexes including central blood pressure on renal arteriolosclerosis has not been investigated. We determined whether vascular function indexes were related to renal arteriolosclerosis and renal clinical outcomes in CKD.
This cross-sectional study was implemented in our hospital. Subjects were in-patients with CKD aged ≥20 years who underwent a renal biopsy. Vascular function indexes included central systolic blood pressure (SBP), cardio-ankle vascular index (CAVI), and renal resistive index. Central SBP was measured non-invasively using an automated device. Arteriolosclerosis was assessed histologically. Renal clinical outcomes included estimated glomerular filtration rate using serum creatinine (eGFRcreat) or cystatin C (eGFRcys), and the urinary albumin-creatinine ratio.
Among vascular function indexes, central SBP was weakly correlated with renal arteriolosclerosis (n = 55). Renal arteriolosclerosis was increased in hypertensive or hyperuricaemic patients, and negatively correlated with serum high-density lipoprotein (HDL) cholesterol and eGFRcys, which were independent risk factors for renal arteriolosclerosis in a stepwise multivariate regression analysis. Of the vascular function indexes, CAVI showed the strongest correlation with all renal clinical outcomes. Central SBP was correlated with only urinary albumin-creatinine ratio, while renal resistive index was correlated with eGFRcreat and urinary albumin-creatinine ratio.
Decreased serum HDL cholesterol was independently and most closely associated with renal arteriolosclerosis. Of the vascular function indexes, CAVI had the greatest impact on renal clinical outcomes, although it was not associated with renal arteriolosclerosis.
高血压在慢性肾脏病(CKD)肾小动脉硬化的发展过程中起关键作用,但包括中心血压在内的血管功能指标对肾小动脉硬化的影响尚未得到研究。我们确定血管功能指标是否与CKD患者的肾小动脉硬化及肾脏临床结局相关。
本横断面研究在我院开展。研究对象为年龄≥20岁且接受肾活检的CKD住院患者。血管功能指标包括中心收缩压(SBP)、心踝血管指数(CAVI)和肾阻力指数。使用自动装置无创测量中心SBP。通过组织学评估小动脉硬化情况。肾脏临床结局包括使用血清肌酐估算的肾小球滤过率(eGFRcreat)或胱抑素C估算的肾小球滤过率(eGFRcys),以及尿白蛋白肌酐比值。
在血管功能指标中,中心SBP与肾小动脉硬化呈弱相关(n = 55)。高血压或高尿酸血症患者的肾小动脉硬化加重,且与血清高密度脂蛋白(HDL)胆固醇和eGFRcys呈负相关,在逐步多因素回归分析中,这两项是肾小动脉硬化的独立危险因素。在血管功能指标中,CAVI与所有肾脏临床结局的相关性最强。中心SBP仅与尿白蛋白肌酐比值相关,而肾阻力指数与eGFRcreat和尿白蛋白肌酐比值相关。
血清HDL胆固醇降低与肾小动脉硬化独立且密切相关。在血管功能指标中,CAVI对肾脏临床结局影响最大,尽管它与肾小动脉硬化无关。